logo biblio digital exactas
logo twitter logo instagram logo whatsapp logo mail

Navegar

Colección

Datos Estadísticas

Lista de

prostate cancer
35
"Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity" (2018) Corapi, E.; Carrizo, G.; Compagno, D.; Laderach, D. Frontiers in immunology. 9:2190
"Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis article" (2018) Gueron, G.;Anselmino, N.;Chiarella, P. (...)Vazquez, E. Cell Death and Disease. 9(2)
"Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer" (2017) Gentilini, L.D.;Jaworski, F.M.;Tiraboschi, C. (...)Compagno, D. Oncotarget. 8(27):44654-44668
"Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer" (2017) Gentilini, L.D.;Jaworski, F.M.;Tiraboschi, C. (...)Compagno, D. Oncotarget. 8(27):44654-44668
"Biological relevance of Hsp90-binding immunophilins in cancer development and treatment" (2016) Mazaira, G.I.;Camisay, M.F.;De Leo, S. (...)Galigniana, M.D. International Journal of Cancer. 138(4):797-808
"Association of HO-1 and BRCA1 is critical for the maintenance of cellular homeostasis in prostate cancer" (2015) Labanca, E.;De Luca, P.;Gueron, G. (...)De Siervi, A. Molecular Cancer Research. 13(11):1455-1464
"Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer" (2015) Zalazar, F.;De Luca, P.;Gardner, K. (...)De Siervi, A. Current Pharmaceutical Biotechnology. 16(6):553-563
"Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer" (2015) Zalazar, F.;De Luca, P.;Gardner, K. (...)De Siervi, A. Current Pharmaceutical Biotechnology. 16(6):553-563
"Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases" (2014) Wan, X.;Corn, P.G.;Yang, J. (...)Navone, N.M. Science Translational Medicine. 6(252)
"Differential effect of heterocyclic d-ribofuranoside derivatives on human prostate cancer cell viability and cell cycle progression" (2014) Gueron, G.;Avanzo, R.E.;Schuster, F. (...)D'Accorso, N.B. Biomedicine and Pharmacotherapy. 68(7):847-854
"Differential effect of heterocyclic d-ribofuranoside derivatives on human prostate cancer cell viability and cell cycle progression" (2014) Gueron, G.;Avanzo, R.E.;Schuster, F. (...)D'Accorso, N.B. Biomedicine and Pharmacotherapy. 68(7):847-854
"Synthesis and cytotoxic evaluation of four new 6E-hydroximinosteroids" (2014) Richmond, V.;Careaga, V.P.;Sacca, P. (...)Maier, M.S. Steroids. 84:7-10
"Glycans and galectins in prostate cancer biology, angiogenesis and metastasis" (2014) Compagno, D.;Gentilini, L.D.;Jaworski, F.M. (...)Laderach, D.J. Glycobiology. 24(10):899-906
"Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice" (2014) Moiola, C.P.;Luca, P.D.;Zalazar, F. (...)De Siervi, A. Clinical Cancer Research. 20(15):4086-4095
"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558
"BRCA1 and p53 regulate critical prostate cancer pathways" (2013) De Luca, P.;Moiola, C.P.;Zalazar, F. (...)De Siervi, A. Prostate Cancer and Prostatic Diseases. 16(3):233-238
"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)
"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)
"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease" (2013) Laderach, D.J.;Gentilini, L.D.;Giribaldi, L. (...)Rabinovich, G.A. Cancer Research. 73(1):86-96
"Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy" (2013) Cotignola, J.;Leonardi, D.B.;Shahabi, A. (...)Vazquez, E. Prostate Cancer and Prostatic Diseases. 16(1):28-34
"Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription" (2012) Moiola, C.;De Luca, P.;Cotignola, J. (...)De Siervi, A. Cellular Physiology and Biochemistry. 30(3):596-608
"Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription" (2012) Moiola, C.;De Luca, P.;Cotignola, J. (...)De Siervi, A. Cellular Physiology and Biochemistry. 30(3):596-608
"Unveiling the association of STAT3 and HO-1 in prostate cancer: Role beyond heme degradation" (2012) Elguero, B.;Gueron, G.;Giudice, J. (...)Vazquez, E. Neoplasia (United States). 14(11):1043-1056
"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221
"Human periprostatic adipose tissue: Its influence on prostate cancer cells" (2012) Sacca, P.A.;Creydt, V.P.;Choi, H. (...)Calvo, J.C. Cellular Physiology and Biochemistry. 30(1):113-122
"Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer" (2011) Chauchereau, A.;Al Nakouzi, N.;Gaudin, C. (...)Fizazi, K. Experimental Cell Research. 317(3):262-275
"Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer" (2011) Ferrando, M.;Gueron, G.;Elguero, B. (...)Vazquez, E. Angiogenesis. 14(4):467-479
"Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer" (2011) Ferrando, M.;Gueron, G.;Elguero, B. (...)Vazquez, E. Angiogenesis. 14(4):467-479
"Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52)" (2011) Sivils, J.C.; Storer, C.L.; Galigniana, M.D.; Cox, M.B. Current Opinion in Pharmacology. 11(4):314-319
"FKBP51 and FKBP52 in signaling and disease" (2011) Storer, C.L.;Dickey, C.A.;Galigniana, M.D. (...)Cox, M.B. Trends in Endocrinology and Metabolism. 22(12):481-490
"Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas" (2009) Labeur, M.; Paez-Pereda, M.; Arzt, E.; Stalla, G.K. Reviews in Endocrine and Metabolic Disorders. 10(2):103-109
"Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells" (2009) Gueron, G.;De Siervi, A.;Ferrando, M. (...)Vazquez, E.S. Molecular Cancer Research. 7(11):1745-1755
"Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer" (2007) Sacca, P.;Meiss, R.;Casas, G. (...)Vazquez, E. British Journal of Cancer. 97(12):1683-1689
"Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer" (2007) Sacca, P.;Meiss, R.;Casas, G. (...)Vazquez, E. British Journal of Cancer. 97(12):1683-1689
"p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells" (2002) Martinez, L.A.;Yang, J.;Vazquez, E.S. (...)Navone, N.M. Carcinogenesis. 23(8):1289-1296